639816-37-8 Usage
Description
METHYL 4-(5-FORMYL-2-THIENYL)BENZENECARBOXYLATE is an organic compound that serves as a key reagent in the synthesis of various chemical compounds. It is characterized by its unique molecular structure, which features a methyl group, a formyl group, and a thiophene ring attached to a benzene ring with a carboxylate group. METHYL 4-(5-FORMYL-2-THIENYL)BENZENECARBOXYLATE plays a crucial role in the development of pharmaceuticals and other chemical products.
Uses
Used in Pharmaceutical Industry:
METHYL 4-(5-FORMYL-2-THIENYL)BENZENECARBOXYLATE is used as a reagent in the synthesis of arylidene-thioxoimidazolidin-4-ones. These synthesized compounds function as inhibitors of the cytolytic protein perforin, which plays a significant role in the immune system. By inhibiting perforin, these compounds have potential applications in the development of treatments for various immune-related disorders and diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 639816-37-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,9,8,1 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 639816-37:
(8*6)+(7*3)+(6*9)+(5*8)+(4*1)+(3*6)+(2*3)+(1*7)=198
198 % 10 = 8
So 639816-37-8 is a valid CAS Registry Number.
639816-37-8Relevant articles and documents
HETEROCYCLIC INTEGRIN AGONISTS
-
Paragraph 0291; 0292, (2018/07/29)
The present invention provides polycyclic oxothioxoimidazolidines, dioxoimidazolines, oxothioxooxazolidines, dioxooxazolidines, and related compounds, which are useful as integrin agonists. Methods for the treatment of integrin-mediated diseases such as cancer are also described.
COMPOUNDS, PREPARATIONS AND USES THEREOF
-
Page/Page column 65, (2011/07/09)
The present invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds and methods for using such compounds as agents or drugs for inhibiting perforin activity and for treating a subject at risk of or susc
